Sort
48,018 grants matching “immunotherapy”
The developmental layers in the CD8+ T cell response to chronic infection
$478,013Brian David Rudd · Cornell University · R01 · FY2021 · AI
The developmental layers in the CD8+ T cell response to chronic infection
$478,013Brian David Rudd · Cornell University · R01 · FY2022 · AI
The developmental layers in the CD8+ T cell response to chronic infection
$477,987Brian David Rudd · Cornell University · R01 · FY2020 · AI
The developmental layers in the CD8+ T cell response to chronic infection
$477,936Brian David Rudd · Cornell University · R01 · FY2019 · AI
The role of the RNA demethylase FTO in metabolic reprogramming of renal cell carcinoma
$477,934Erinn B Rankin · Stanford University · R01 · FY2023 · CA
Project 3: Development of Novel Antibody Drug Conjugates for the Treatment of Osteosarcoma
$477,912Richard G Gorlick · University Of Tx Md Anderson Can Ctr · P50 · FY2025 · CA
Developing whole-body computational phantoms for blood dosimetry to model the impact of radiation on the immune system
$477,849Harald Paganetti · Massachusetts General Hospital · R01 · FY2022 · CA
Mechanisms of cell death in cutaneous melanoma
$477,822Andrew E Aplin · Thomas Jefferson University · R01 · FY2025 · CA
Mechanisms of cell death in cutaneous melanoma
$477,822Andrew E Aplin · Thomas Jefferson University · R01 · FY2021 · CA
Role of IL-12 family cytokines in human autoimmune Uveitis
$477,821Charles E Egwuagu · National Eye Institute · ZIA · FY2021 · EY
Repurposing Glucosylceramide Synthase to Promote Mitochondrial Lethality and Potentiate an Anti-Tumor Immune Response in Triple-Negative Breast Cancer
$477,817Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer
$477,800Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2023 · CA
Designing T cells to Functionally Cure HIV-1 infection
$477,788James L Riley · University Of Pennsylvania · U19 · FY2018 · AI
Senescence as a Therapeutic Endpoint
$477,787Meenhard Herlyn · Wistar Institute · P01 · FY2016 · CA
Project 2: Redirecting pre-existing anti-viral immunity to HNSCCs with APECs
$477,775Thorsten Roman Mempel · Yale University · P01 · FY2023 · CA
Senescence as a Therapeutic Endpoint
$477,725Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
$477,698Marcus E Peter · Northwestern University At Chicago · R01 · FY2025 · CA
Data Management and Analysis Core
$477,664Aris Floratos · Columbia University Health Sciences · U19 · FY2017 · AI
The Adenosinergic Pathway in Tumor-derived Exosomes
$477,653Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$477,643Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$477,643Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$477,643Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Enhancing neoadjuvant chemotherpay responses with targeted T cells
$477,633Gerold Bepler · Wayne State University · R01 · FY2015 · CA
The role of sex in the life cycle and transmission of Pneumocystis
$477,607Melanie T Cushion · University Of Cincinnati · R01 · FY2021 · HL
Data Management and Analysis Core
$477,567Aris Floratos · Columbia University Health Sciences · U19 · FY2018 · AI